Kestrel Therapeutics Revenue

Biotechnology Research • Boston, Massachusetts, United States • 21-50 Employees

Kestrel Therapeutics revenue & valuation

Annual revenue	$2,309,985
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$7,400,000
Total funding	$40,000,000

Key Contacts at Kestrel Therapeutics

Barbara Sosnowski

Member Board Of Directors

Tammy Pasqualini

Senior Director Clinical Development Operations

Jiali Phd

Director Of Biology

Huan Rui

Associate Director

Yeon Sook Choi

Director

Nicholas Larsen

Senior Director Of Biophysics And Structural Biology

Ivan Jewett

Director Of Medicinal Chemistry

Elizabeth Wharton

Director, Head Of Operations And Administration

Yun Zhang

Associate Director

Fabien Boulineau

Director Of Analytical Development

Company overview

Headquarters	Pagliuca Harvard Life Lab, 127 Western Ave, Boston, MA 02134, US
Phone number	+16174603772
Websites	kestreltherapeutics.com kestreltherpeutics.com
Employees	21-50
Socials

Kestrel Therapeutics Email Formats

Kestrel Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@kestreltherapeutics.com), used 86.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@kestreltherapeutics.com	86.4%
{first name}.{last name}	john.doe@kestreltherapeutics.com	13.6%

About Kestrel Therapeutics

Our goal is to bring new therapy to cancer’s most frequently mutated oncogenic target. Kestrel is discovering and developing new molecules to treat intractable cancers. We are starting with potent inhibitors of pan-oncogenic-RAS. We rely on exceptional science, and our focus, always, is on patients.

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Director

C-Suite

Entry

Employees by Department

Kestrel Therapeutics has 8 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Kestrel Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-01-01	4	$40,000,000

Funding Insights

$40,000,000

Total funding amount

$40,000,000

Most recent funding amount

Number of funding rounds

Kestrel Therapeutics Tech Stack

Discover the technologies and tools that power Kestrel Therapeutics's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Site Kit

Analytics

jQuery UI

JavaScript libraries

Google Maps

Maps

Hello Elementor

WordPress themes

Elementor

Page builders

Microsoft 365

jQuery Migrate

JavaScript libraries

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Frequently asked questions

Kestrel Therapeutics is located in Boston, Massachusetts, US.

You can reach Kestrel Therapeutics at +16174603772.

Kestrel Therapeutics generates an estimated annual revenue of $2,309,985. This revenue figure reflects the company's market position and business performance in its industry.

Kestrel Therapeutics has an estimated valuation of $7,400,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Kestrel Therapeutics has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Kestrel Therapeutics has raised a total of $40,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Kestrel Therapeutics

Barbara Sosnowski

Member Board Of Directors

Tammy Pasqualini

Senior Director Clinical Development Operations

Jiali Phd

Director Of Biology

Huan Rui

Associate Director

Yeon Sook Choi

Director

Nicholas Larsen